Cargando…

Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10

Our previous genome-wide association study identified the anti-tumor ligand MHC class I polypeptide-related sequence A (MICA) as a susceptibility gene for hepatitis C virus-induced hepatocellular carcinoma (HCC). We subsequently proved that pharmacological restoration of membrane-bound MICA in HCC c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Kaku, Arai, Jun, Stephanou, Anthony, Kato, Naoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922358/ https://www.ncbi.nlm.nih.gov/pubmed/29721164 http://dx.doi.org/10.18632/oncotarget.24568

Ejemplares similares

Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro
por: Goto, Kaku, et al.
Publicado: (2016)

The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016)

The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family
por: Kelwick, Richard, et al.
Publicado: (2015)

Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases
por: Dreymueller, D., et al.
Publicado: (2017)

A Disintegrin and Metalloproteinase—Control Elements in Infectious Diseases
por: Aljohmani, Ahmad, et al.
Publicado: (2020)

A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development
por: Toonen, Joseph A., et al.
Publicado: (2016)

A Disintegrin and Metalloproteinase 10 (ADAM10) Is Essential for Oligodendrocyte Precursor Development and Myelination in the Mouse Brain
por: Guo, Dazhi, et al.
Publicado: (2022)

Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma
por: Honda, Hiroki, et al.
Publicado: (2017)

Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17
por: Yang, Guang, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
por: Oh, Sooyeon, et al.
Publicado: (2020)

Deficiency of the Metalloproteinase-Disintegrin ADAM8 Is Associated with Thymic Hyper-Cellularity
por: Gossens, Klaus, et al.
Publicado: (2010)

Diagnostic and prognostic value of a disintegrin and metalloproteinase-17 in patients with gliomas
por: WU, BIN, et al.
Publicado: (2014)

A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma
por: Kanzaki, Hiroyuki, et al.
Publicado: (2016)

Inhibition of hepatocellular carcinoma cell proliferation, migration, and invasion by a disintegrin and metalloproteinase-17 inhibitor TNF484
por: Xia, Changhong, et al.
Publicado: (2019)

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram
por: Zhang, Gong, et al.
Publicado: (2022)

Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12
por: Qi, Yue, et al.
Publicado: (2014)

Molecular characterization and expression of a disintegrin and metalloproteinase with thrombospondin motifs 8 in chicken
por: Lee, Ra Ham, et al.
Publicado: (2018)

Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo
por: Altmeppen, Hermann C, et al.
Publicado: (2011)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

A Disintegrin and Metalloproteinase 9 Is Involved in Ectodomain Shedding of Receptor-Binding Cancer Antigen Expressed on SiSo Cells
por: Sonoda, Kenzo, et al.
Publicado: (2014)

A metalloproteinase of the disintegrin and metalloproteinases and the ThromboSpondin Motifs 6 as a novel marker for colon cancer: functional experiments
por: Wang, Yun-Peng, et al.
Publicado: (2020)

Biological potentials for a family of disintegrin and metalloproteinase (ADAMDEC)-1 in mouse normal pregnancy
por: KUNIYOSHI, Nobue, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2022)

Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes
por: Lee, Alan C. H., et al.
Publicado: (2015)

Expression of Migration-Related Genes in Human Colorectal Cancer and Activity of a Disintegrin and Metalloproteinase 17
por: Walkiewicz, Katarzyna, et al.
Publicado: (2016)

A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer
por: Chung, Hye Won, et al.
Publicado: (2019)

A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation
por: Yang, Xiaoyuan, et al.
Publicado: (2018)

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase Protein 8 (ADAM 8) in Autism Spectrum Disorder: Links to Neuroinflammation
por: Al-Ayadhi, Laila, et al.
Publicado: (2023)

Single‐nucleotide polymorphisms in the coding region of a disintegrin and metalloproteinase with thrombospondin motifs 4 and hepatocellular carcinoma: A retrospective case‐control study
por: Wang, Xing‐Zhizi, et al.
Publicado: (2019)

Effect of type 2 diabetes on A disintegrin and metalloprotease 10
por: Lam, Sum, et al.
Publicado: (2022)

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
por: Permatasari, Dian Agustina, et al.
Publicado: (2019)

The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor
por: Atfi, Azeddine, et al.
Publicado: (2007)

Upregulation of a disintegrin and metalloproteinase-33 by VEGF in human airway smooth muscle cells: Implications for asthma
por: Pei, Qing-Mei, et al.
Publicado: (2016)

Detectable A Disintegrin and Metalloproteinase With Thrombospondin Motifs-1 in Serum Is Associated With Adverse Outcome in Pediatric Sepsis
por: Boeddha, Navin P., et al.
Publicado: (2021)

A Novel Pro-Inflammatory Mechanosensing Pathway Orchestrated by the Disintegrin Metalloproteinase ADAM15 in Synovial Fibroblasts
por: Janczi, Tomasz, et al.
Publicado: (2021)

Potential role of a disintegrin and metalloproteinase-17 (ADAM17) in age-associated ventricular remodeling of rats
por: Liu, Hainiang, et al.
Publicado: (2019)

Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy
por: Moriwaki, Michika, et al.
Publicado: (2022)

Possible Therapeutic Potential of Disulfiram for Multiple Myeloma
por: Weiser Drozdkova, Denisa, et al.
Publicado: (2021)

Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113
por: SHAO, YUAN, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b8dceeiq7nrgg4lesm37b8qhvd